Optimal Non-Pharmaceutical Interventions Considering Limited Healthcare System Capacity and Economic Costs in the Republic of Korea

Author:

Lim Yuna,Ko Youngsuk,Mendoza Renier,Mendoza Victoria May P.,Lee Jongmin,Jung Eunok

Abstract

AbstractDue to the relatively low severity and fatality rates of the omicron variant of COVID-19, strict non-pharmaceutical interventions (NPIs) with high economic costs may not be necessary. We develop a mathematical model of the COVID-19 outbreak in Korea that considers NPIs, variants, medical capacity, and economic costs. Using optimal control theory, we propose an optimal strategy for the omicron period. To suggest a realistic strategy, we consider limited hospital beds for severe cases and incorporate it as a penalty term in the objective functional using a logistic function. This transforms the constrained problem into an unconstrained one. Given that the solution to the optimal control problem is continuous, we propose the adoption of a sub-optimal control as a more practically implementable alternative. Our study demonstrates how to strategically balance the tradeoff between minimizing the economic cost for NPIs and ensuring that the number of severe cases in hospitals is manageable.

Publisher

Cold Spring Harbor Laboratory

Reference59 articles.

1. R Manjunath , Santosh L Gaonkar , Ebraheem Abdu Musad Saleh , and Kakul Husain . A comprehensive review on covid-19 omicron (b. 1.1. 529) variant. Saudi Journal of Biological Sciences, page 103372, 2022.

2. Literature review of omicron: a grim reality amidst covid-19;Microorganisms,2022

3. Korea Disease Control and Prevention Agency, PUBLIC HEALTH WEEKLY REPORT, PHWR (Vol.15, No.10, 2022). https://www.kdca.go.kr/board/board.es?mid=a20602010000&bid=0034&list_no=718944&act=view#. Accessed: February 25, 2023.

4. Epidemiological and economic impact of covid-19 in the us;Scientific reports,2021

5. Projections of the transmission of the omicron variant for toronto, ontario, and canada using surveillance data following recent changes in testing policies;Infectious Disease Modelling,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3